Navigation Links
UK company to demonstrate their commercially effective graphene production process
Date:4/6/2012

al applications and to explain their split plasma process and the characterisation capability of the technology.

Haydale has now started to offer a range of GNPs and other materials to the open market under the brand HDPlas.

Critically, organisations can now use the HDPlas product range for product prototyping and analysis. Haydale offers expertise in running pilot trials to evaluate the effect their GNPs have on the client's materials and products and crucially assessing their suitability for large scale production. The key to take up is to know that commercial quantities are then available.

Haydale, who are moving to new purpose built state of the art facilities in South Wales, is now able to supply HDPlas from stock as well as to order. A technical analysis sheet, which includes typical characterisation data and representational images, has been prepared and will accompany the goods so that the buyer can instantly see the product specification without needing to spend valuable time and resource in independent verification procedures.

Commenting, Chairman Tony Belisario said:

"We are all very excited by the opportunity our patented process offers as a critical element of material replacement for enhanced performance of a vast array of potential applications. The market is looking for ways of using the new wonder material Graphene and we believe that we have the process that can now make the commercial quantities required by global companies. The cutting edge technology has been peer reviewed and we can now do "what it says on the tin". We have proved we can personalise solutions to a clients specific needs in a cost effective, environmentally friendly and innovative way. Graphene 2012 is a perfect place to launch our technology and we expect significant interest in Haydale."


'/>"/>

Contact: Trevor Phillips
trevor.phillips@hermesfinancialpr.co.uk
44-788-915-3628
Hermes Financial Public Relations
Source:Eurekalert

Page: 1 2

Related biology technology :

1. Regado Biosciences, Inc. to Present at Needham & Companys 11th Annual Healthcare Conference in New York, NY
2. Nycomed, a Takeda Company, Launches Omnaris® Nasal Spray in the UAE for the Treatment of Allergic Rhinitis
3. Receptos to Present at the Cowen and Company 32nd Annual Health Care Conference
4. Incline Therapeutics to Present at the Cowen and Company 32nd Annual Health Care Conference
5. Regado Biosciences, Inc. to Present at the Cowen and Company 32nd Annual Health Care Conference in Boston, MA
6. Aneesh Chopra to Serve as Senior Advisor to The Advisory Board Company
7. Meaningful Use Stage Two: The Advisory Board Company Helps Hospitals Set Strategy
8. Leading Pharmaceutical Marketing Research and Consulting Company Introduces Intelligent Efficiency Program
9. Oxford Finance Provides $15 Million Senior Secured Credit Facility to Private Equity Backed Healthcare Services Company
10. Fox Insurance Company Awarded $3.3 Million in Arbitration Against Former Pharmacy Benefit Manager
11. Monsanto Declared Worst Company of 2011 by NaturalSociety
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... , Aug. 28, 2015 /PRNewswire/ - RepliCel ... stage regenerative medicine company focused on the development ... for the quarter ended June 30, 2015, corporate ... and management report are available at www.sedar.com ... . "RepliCel expects to launch ...
(Date:8/28/2015)... NY (PRWEB) , ... August 28, 2015 , ... Since the initial launch of FireflySci ... their quirky humor and excellent customer service. Images such as the Fonz in a ... to add some flavor to the humdrum spectroscopy field. , FireflySci is proud ...
(Date:8/27/2015)... ... August 27, 2015 , ... Capital Edge Consulting , ... problems, is pleased to announce their ranking as one of the top 5000 companies ... fastest-growing private companies across the nation. , “It is truly an honor to be ...
(Date:8/27/2015)... 27, 2015 /PRNewswire/ - Portage Biotech Inc. ("Portage") ... Biohaven Pharmaceutical Holding Company Limited (Biohaven), announced today ... study of BHV-0223, a glutamate modulating agent. Biohaven ... and recently obtained clearance from the U.S. Food ... testing. Portage holds 54% equity interest in Biohaven, ...
Breaking Biology Technology:RepliCel Reports Second Quarter 2015 Financial Results 2RepliCel Reports Second Quarter 2015 Financial Results 3RepliCel Reports Second Quarter 2015 Financial Results 4RepliCel Reports Second Quarter 2015 Financial Results 5Cuvette Manufacturer FireflySci Launches Back to School Deals with Complimentary Shipping On All Orders 2Capital Edge Consulting Makes Inc. 5000 List of America’s Fastest-Growing Private Companies 2Capital Edge Consulting Makes Inc. 5000 List of America’s Fastest-Growing Private Companies 3Portage's Biohaven doses first human subject in Phase 1 trial with lead drug candidate BHV-0223 2Portage's Biohaven doses first human subject in Phase 1 trial with lead drug candidate BHV-0223 3Portage's Biohaven doses first human subject in Phase 1 trial with lead drug candidate BHV-0223 4
... WALTHAM, Mass., Aug. 6 Interleukin ... it will host a conference call and webcast on Thursday, August ... developments and second quarter financial results. , , ... The live webcast and replay access of the teleconference will be ...
... , , SYDNEY, Aug. ... increased revenues in the breast cancer therapeutics market in Australia. As the ... breast cancer patients in the country was 164,814 in 2008. This ... is second to lung cancer as the cause of death among women. ...
... YORK, Aug. 5 Keryx Biopharmaceuticals, Inc. (Nasdaq: ... acquisition, development and commercialization of medically important, novel pharmaceutical ... disease and cancer (the "Company"), today announced its results ... , At June 30, 2009, the ...
Cached Biology Technology:The Breast Cancer Therapeutics Market in Australia 2The Breast Cancer Therapeutics Market in Australia 3Keryx Biopharmaceuticals, Inc. Announces Second Quarter 2009 Financial Results 2Keryx Biopharmaceuticals, Inc. Announces Second Quarter 2009 Financial Results 3Keryx Biopharmaceuticals, Inc. Announces Second Quarter 2009 Financial Results 4Keryx Biopharmaceuticals, Inc. Announces Second Quarter 2009 Financial Results 5Keryx Biopharmaceuticals, Inc. Announces Second Quarter 2009 Financial Results 6
(Date:7/31/2015)... juillet 2015 La 10e Conférence internationale ... organisée par le BGI du 22 au 25 ... en Chine. La conférence célèbre son ... 2006, l,ICG est devenue l,une des réunions annuelles ... « omiques » et c,est aussi la plus dynamique, la ...
(Date:7/31/2015)... NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" or ... growing mobile commerce market and creator of the Wocket® ... 62/198989 for ELECTRONIC CRYPTO-CURRENCY MANAGEMENT METHOD AND ... advance crypto-currencies such as Bitcoin into the consumer market ... to manage all payments.  The technology ...
(Date:7/27/2015)... , July 27, 2015  Synaptics Inc. (NASDAQ: ... interface solutions, today announced that Huawei has selected ... solution for its stylish smartwatch. Huawei chose the ... reliability, low power and highly responsive human interface ... Huawei designers also required a classic round watch ...
Breaking Biology News(10 mins):La 10e International Conference on Genomics (ICG-10) doit s'ouvrir en octobre 2La 10e International Conference on Genomics (ICG-10) doit s'ouvrir en octobre 3NXT-ID Patents Electronic Crypto-Currency Management Technology 2NXT-ID Patents Electronic Crypto-Currency Management Technology 3NXT-ID Patents Electronic Crypto-Currency Management Technology 4Synaptics Touchscreen Solution Powers New Huawei Watch 2Synaptics Touchscreen Solution Powers New Huawei Watch 3
... projects focus on either the development of new technologies ... The Swiss National Science Foundation (SNSF) approved six RTD-projects ... groups from both Swiss Federal Institutes of Technology (ETH ... Universities of Basel, Lausanne, Geneva and Zurich. The Friedrich-Miescher ...
... guidelines designed to standardize and optimize the diagnosis, treatment, ... an uncommon and challenging form of thyroid cancer, have ... online ahead of print in Thyroid , a ... www.liebertpub.com ). The guidelines are available free online at ...
... are one step closer to building low cost ... environmental monitoring. At the IEEE Reconfigurable Architectures Workshop ... from the Jacobs School of Engineering presented a ... reconfigurable hardware rather than competing hardware platforms for ...
Cached Biology News:Swiss Initiative in Systems Biology launches new projects 2First comprehensive guidelines for managing medullary thyroid carcinoma published in Thyroid journal 2Toward cheap underwater sensor nets 2Toward cheap underwater sensor nets 3
Rat Lung Fibroblasts (RLF) (>500,000 cells)...
Rat Aortic Endothelial Cells (RAOEC) (>500,000 cells)...
...
... is suitable for use with a wide ... through to water and some of the ... capable of removing water and organic solvents ... tubes, microplates, vials and round bottom flasks; ...
Biology Products: